Cargando…
The Long Non-Coding RNA Prader Willi/Angelman Region RNA5 (PAR5) Is Downregulated in Anaplastic Thyroid Carcinomas Where It Acts as a Tumor Suppressor by Reducing EZH2 Activity
Anaplastic thyroid carcinoma (ATC) represents one the most aggressive neoplasias in humans, and, nowadays, limited advances have been made to extend the survival and reduce the mortality of ATC. Thus, the identification of molecular mechanism underlying its progression is needed. Here, we evaluated...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017000/ https://www.ncbi.nlm.nih.gov/pubmed/31963578 http://dx.doi.org/10.3390/cancers12010235 |
_version_ | 1783497105410621440 |
---|---|
author | Pellecchia, Simona Sepe, Romina Decaussin-Petrucci, Myriam Ivan, Cristina Shimizu, Masayoshi Coppola, Carmela Testa, Domenico Calin, George Adrian Fusco, Alfredo Pallante, Pierlorenzo |
author_facet | Pellecchia, Simona Sepe, Romina Decaussin-Petrucci, Myriam Ivan, Cristina Shimizu, Masayoshi Coppola, Carmela Testa, Domenico Calin, George Adrian Fusco, Alfredo Pallante, Pierlorenzo |
author_sort | Pellecchia, Simona |
collection | PubMed |
description | Anaplastic thyroid carcinoma (ATC) represents one the most aggressive neoplasias in humans, and, nowadays, limited advances have been made to extend the survival and reduce the mortality of ATC. Thus, the identification of molecular mechanism underlying its progression is needed. Here, we evaluated the long non-coding RNA (lncRNA) expression profile of nine ATC in comparison with five normal thyroid tissues by a lncRNA microarray. By this analysis, we identified 19 upregulated and 28 downregulated lncRNAs with a fold change >1.1 or <−1.1 and p-value < 0.05, in ATC samples. Some of them were subsequently validated by qRT-PCR. Then, we investigated the role of the lncRNA Prader Willi/Angelman region RNA5 (PAR5), drastically and specifically downregulated in ATC. The restoration of PAR5 reduces proliferation and migration rates of ATC-derived cell lines indicating that its downregulation contributes to thyroid cancer progression. Our results suggest that PAR5 exerts its anti-oncogenic role by impairing Enhancer of Zeste Homolog 2 (EZH2) oncogenic activity since we demonstrated that PAR5 interacts with it in thyroid cancer cell lines, reducing EZH2 protein levels and its binding on the E-cadherin promoter, relieving E-cadherin from the negative regulation by EZH2. Consistently, EZH2 is overexpressed in ATC, but not in differentiated thyroid carcinomas. The results reported here define a tumor suppressor role for PAR5 in undifferentiated thyroid neoplasias, further highlighting the pivotal role of lncRNAs in thyroid carcinogenesis. |
format | Online Article Text |
id | pubmed-7017000 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70170002020-02-28 The Long Non-Coding RNA Prader Willi/Angelman Region RNA5 (PAR5) Is Downregulated in Anaplastic Thyroid Carcinomas Where It Acts as a Tumor Suppressor by Reducing EZH2 Activity Pellecchia, Simona Sepe, Romina Decaussin-Petrucci, Myriam Ivan, Cristina Shimizu, Masayoshi Coppola, Carmela Testa, Domenico Calin, George Adrian Fusco, Alfredo Pallante, Pierlorenzo Cancers (Basel) Article Anaplastic thyroid carcinoma (ATC) represents one the most aggressive neoplasias in humans, and, nowadays, limited advances have been made to extend the survival and reduce the mortality of ATC. Thus, the identification of molecular mechanism underlying its progression is needed. Here, we evaluated the long non-coding RNA (lncRNA) expression profile of nine ATC in comparison with five normal thyroid tissues by a lncRNA microarray. By this analysis, we identified 19 upregulated and 28 downregulated lncRNAs with a fold change >1.1 or <−1.1 and p-value < 0.05, in ATC samples. Some of them were subsequently validated by qRT-PCR. Then, we investigated the role of the lncRNA Prader Willi/Angelman region RNA5 (PAR5), drastically and specifically downregulated in ATC. The restoration of PAR5 reduces proliferation and migration rates of ATC-derived cell lines indicating that its downregulation contributes to thyroid cancer progression. Our results suggest that PAR5 exerts its anti-oncogenic role by impairing Enhancer of Zeste Homolog 2 (EZH2) oncogenic activity since we demonstrated that PAR5 interacts with it in thyroid cancer cell lines, reducing EZH2 protein levels and its binding on the E-cadherin promoter, relieving E-cadherin from the negative regulation by EZH2. Consistently, EZH2 is overexpressed in ATC, but not in differentiated thyroid carcinomas. The results reported here define a tumor suppressor role for PAR5 in undifferentiated thyroid neoplasias, further highlighting the pivotal role of lncRNAs in thyroid carcinogenesis. MDPI 2020-01-17 /pmc/articles/PMC7017000/ /pubmed/31963578 http://dx.doi.org/10.3390/cancers12010235 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Pellecchia, Simona Sepe, Romina Decaussin-Petrucci, Myriam Ivan, Cristina Shimizu, Masayoshi Coppola, Carmela Testa, Domenico Calin, George Adrian Fusco, Alfredo Pallante, Pierlorenzo The Long Non-Coding RNA Prader Willi/Angelman Region RNA5 (PAR5) Is Downregulated in Anaplastic Thyroid Carcinomas Where It Acts as a Tumor Suppressor by Reducing EZH2 Activity |
title | The Long Non-Coding RNA Prader Willi/Angelman Region RNA5 (PAR5) Is Downregulated in Anaplastic Thyroid Carcinomas Where It Acts as a Tumor Suppressor by Reducing EZH2 Activity |
title_full | The Long Non-Coding RNA Prader Willi/Angelman Region RNA5 (PAR5) Is Downregulated in Anaplastic Thyroid Carcinomas Where It Acts as a Tumor Suppressor by Reducing EZH2 Activity |
title_fullStr | The Long Non-Coding RNA Prader Willi/Angelman Region RNA5 (PAR5) Is Downregulated in Anaplastic Thyroid Carcinomas Where It Acts as a Tumor Suppressor by Reducing EZH2 Activity |
title_full_unstemmed | The Long Non-Coding RNA Prader Willi/Angelman Region RNA5 (PAR5) Is Downregulated in Anaplastic Thyroid Carcinomas Where It Acts as a Tumor Suppressor by Reducing EZH2 Activity |
title_short | The Long Non-Coding RNA Prader Willi/Angelman Region RNA5 (PAR5) Is Downregulated in Anaplastic Thyroid Carcinomas Where It Acts as a Tumor Suppressor by Reducing EZH2 Activity |
title_sort | long non-coding rna prader willi/angelman region rna5 (par5) is downregulated in anaplastic thyroid carcinomas where it acts as a tumor suppressor by reducing ezh2 activity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017000/ https://www.ncbi.nlm.nih.gov/pubmed/31963578 http://dx.doi.org/10.3390/cancers12010235 |
work_keys_str_mv | AT pellecchiasimona thelongnoncodingrnapraderwilliangelmanregionrna5par5isdownregulatedinanaplasticthyroidcarcinomaswhereitactsasatumorsuppressorbyreducingezh2activity AT seperomina thelongnoncodingrnapraderwilliangelmanregionrna5par5isdownregulatedinanaplasticthyroidcarcinomaswhereitactsasatumorsuppressorbyreducingezh2activity AT decaussinpetruccimyriam thelongnoncodingrnapraderwilliangelmanregionrna5par5isdownregulatedinanaplasticthyroidcarcinomaswhereitactsasatumorsuppressorbyreducingezh2activity AT ivancristina thelongnoncodingrnapraderwilliangelmanregionrna5par5isdownregulatedinanaplasticthyroidcarcinomaswhereitactsasatumorsuppressorbyreducingezh2activity AT shimizumasayoshi thelongnoncodingrnapraderwilliangelmanregionrna5par5isdownregulatedinanaplasticthyroidcarcinomaswhereitactsasatumorsuppressorbyreducingezh2activity AT coppolacarmela thelongnoncodingrnapraderwilliangelmanregionrna5par5isdownregulatedinanaplasticthyroidcarcinomaswhereitactsasatumorsuppressorbyreducingezh2activity AT testadomenico thelongnoncodingrnapraderwilliangelmanregionrna5par5isdownregulatedinanaplasticthyroidcarcinomaswhereitactsasatumorsuppressorbyreducingezh2activity AT calingeorgeadrian thelongnoncodingrnapraderwilliangelmanregionrna5par5isdownregulatedinanaplasticthyroidcarcinomaswhereitactsasatumorsuppressorbyreducingezh2activity AT fuscoalfredo thelongnoncodingrnapraderwilliangelmanregionrna5par5isdownregulatedinanaplasticthyroidcarcinomaswhereitactsasatumorsuppressorbyreducingezh2activity AT pallantepierlorenzo thelongnoncodingrnapraderwilliangelmanregionrna5par5isdownregulatedinanaplasticthyroidcarcinomaswhereitactsasatumorsuppressorbyreducingezh2activity AT pellecchiasimona longnoncodingrnapraderwilliangelmanregionrna5par5isdownregulatedinanaplasticthyroidcarcinomaswhereitactsasatumorsuppressorbyreducingezh2activity AT seperomina longnoncodingrnapraderwilliangelmanregionrna5par5isdownregulatedinanaplasticthyroidcarcinomaswhereitactsasatumorsuppressorbyreducingezh2activity AT decaussinpetruccimyriam longnoncodingrnapraderwilliangelmanregionrna5par5isdownregulatedinanaplasticthyroidcarcinomaswhereitactsasatumorsuppressorbyreducingezh2activity AT ivancristina longnoncodingrnapraderwilliangelmanregionrna5par5isdownregulatedinanaplasticthyroidcarcinomaswhereitactsasatumorsuppressorbyreducingezh2activity AT shimizumasayoshi longnoncodingrnapraderwilliangelmanregionrna5par5isdownregulatedinanaplasticthyroidcarcinomaswhereitactsasatumorsuppressorbyreducingezh2activity AT coppolacarmela longnoncodingrnapraderwilliangelmanregionrna5par5isdownregulatedinanaplasticthyroidcarcinomaswhereitactsasatumorsuppressorbyreducingezh2activity AT testadomenico longnoncodingrnapraderwilliangelmanregionrna5par5isdownregulatedinanaplasticthyroidcarcinomaswhereitactsasatumorsuppressorbyreducingezh2activity AT calingeorgeadrian longnoncodingrnapraderwilliangelmanregionrna5par5isdownregulatedinanaplasticthyroidcarcinomaswhereitactsasatumorsuppressorbyreducingezh2activity AT fuscoalfredo longnoncodingrnapraderwilliangelmanregionrna5par5isdownregulatedinanaplasticthyroidcarcinomaswhereitactsasatumorsuppressorbyreducingezh2activity AT pallantepierlorenzo longnoncodingrnapraderwilliangelmanregionrna5par5isdownregulatedinanaplasticthyroidcarcinomaswhereitactsasatumorsuppressorbyreducingezh2activity |